SkinIO in the Press

SkinIO donates to the Nevada Childhood Cancer Foundation (NCCF) to support NCCF's mission to provide care, compassion, and critical services to children battling life-threatening illnesses and the families who stand by them. Read more.

SkinIO donates to Ronald McDonald House Charities (RMHC) of San Diego following a recent skin cancer screening event in the area. Read more.

SkinIO donates to the Triangle Park Community Center, a grassroots organization dedicated to creating a community of hope and resilience in Jersey City’s historically underserved Greenville neighborhood. Read more.

SkinIO donates to Ronald McDonald House of Dallas (RMHD) to support the organization’s ongoing outreach efforts and its commitment to bringing comfort, connection, and care to families navigating serious medical conditions. Read more.

SkinIO donates to Ronald McDonald House Charities of Denver (RMHC-Denver) to support the Aurora House and the families it serves. Read more.

SkinIO presents during the Innovator Spotlight: Breakthroughs in Early Cancer Detection at the MSK Direct Benefits Leaders’ Summit on May 5th in New York City. Read more.

SkinIO donates to City of Dreams, a San Francisco-based nonprofit dedicated to empowering youth in underserved neighborhoods through mentorship, life skills development, and community engagement. Read more.

SkinIO attends ACP Employee Health & Wellness Conference, an exclusive, invitation-only event connecting top benefits executives with innovative healthcare solution providers. Read more.

SkinIO showcases cutting-edge skin cancer screening solution and connecting with industry leaders driving innovation in healthcare at the 2024 HLTH Conference on October 18th in Las Vegas.

SkinIO brings access to skin cancer prevention to vulnerable patient population during COVID-19.

MATTER member Kyoko Crawford, co-founder and CEO of SkinIO, is on a mission to reduce the rate of skin cancer through early screening. With SkinIO, anyone with a smartphone can screen themselves for skin cancer and get connected to the right dermatologist at the right time.

SkinIO, which offers a teledermatology app for remote consultation, is providing at-home and on-site skin cancer screenings to employees of Signature Custom Cabinetry and Aspire Ventures, a venture capital firm and founder of the Innovation Lab.

Skin cancer is highly treatable if caught early. As part of Skin Cancer Awareness Month, Reset talks with the founder of an app that provides early detection and screening for melanoma.

SkinIO’s total body photography, paired with AI-powered image analysis, helps patients map their entire skin surface and figure out what matters, outside of an inaccessible dermatologist’s office.

Kyoko Crawford is the CEO if SkinIO and was recently named to Crain’s Chicago’s 40 under 40. Her degree in Biomedical Engineering from Harvard University allowed her to explore the overlap of business entrepreneurship and biotech – and today she applies this to develop innovative health solutions.

Chicago-based startup SkinIO has developed a skin screening app that can help with the early detection of the most common form of cancer by first analyzing photos snapped with a smartphone. The technology has intrigued the Penn Medicine- and Capital Blue Cross-affiliated Smart Health Innovation Lab, which announced this week that the SkinIO has joined the healthcare technology accelerator.

SkinIO stood out to us as a visionary leader in the teledermatology space, and we’re excited about the access, prevention and cancer detection capabilities the company will bring to our local community in 2022.

After running a New York City-based technology development consultancy for more than a decade, Kyoko Crawford started thinking about launching something tangible— a product she could bring to life.

I just wanted to take a second and say how amazed I am with SkinIO. I’ve been using it for a little over a year, so I’m starting to have folks come back in for their second photo sets... This young lady came in for her second scan. SkinIO flagged this spot as new, about 2mm. Didn’t like how it looked under the dermatoscope. It was very asymmetric with globules of pigment. Came back severely dysplastic nevus cannot rule out melanoma! No way a human would have noticed that.

The global COVID-19 pandemic makes clear the critical need for doctors to connect with patients virtually and today SkinIO, a digital mole-mapping system, announced SkinIO Teledermatology, a new platform that allows dermatologists to capture high-quality from patients to enable the best possible remote dermatological care.

Dr. Deirdre Hooper from Audubon Dermatology in New Orleans, LA talks to Meg Gatto from Fox 8 Local News about SkinIO’s innovative iPad-based imaging.

Nextech Systems, a leading provider of healthcare technology solutions for specialty physician practices, today announces its new partnership with SkinIO. This partnership allows Nextech’s dermatology clients to integrate with the latest technology in healthcare that provides a fast and easy in-office full-body imaging system.

Although some smartphone applications are designed for total body photography (TBP), few offer the specificity that enables self- as well as dermatologist-, detection of new lesions, or change in lesion color or in size as little as 1mm, on an ongoing basis. The aim of this study is to assess the sensitivity of a novel TBP application in the detection of changes to color and size of simulated skin lesions.

Where we think this technology can play a role is to take the onus out of deciding what to target as a consumer patient.

The Chicago-based startup’s goal is to enable patients to monitor their skin over time, thereby improving the chances of detecting skin cancer early.